Skip to content

Psychedelic-Assisted Psychotherapy for TRD: An Umbrella Review [Clinical Psychology Topic 331]

Juan Moises de la Serna

Zenodo (CERN European Organization for Nuclear Research) April 4, 2026 DOI: 10.5281/zenodo.19417228 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Umbrella review Peer reviewed
Topics Psilocybin Psychedelic-assisted therapy
Keywords Medline Cognitive therapy Context archaeology Psychotherapist
Key findings Psilocybin-assisted therapy shows consistent efficacy for depression and anxiety, with moderate to large effect sizes, supporting the Neural-Connectivity Re-set Model.

Abstract

A high-rigor Umbrella Review (v7.0) on the Neural-Connectivity Re-set Model (NCRM) and psilocybin efficacy

Comparable studies

Other systematic reviews and meta-analyses on psilocybin and psychedelic-assisted therapy, most cited first.

Study Year Design Participants
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy 2020 Systematic review
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. Participants in studies of psychedelic therapy for depressive symptoms (Major... 2023 Systematic review with meta-analysis n = 14
Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. Patients diagnosed with life-threatening illnesses or major depressive disorder 2023 Systematic review and meta-analysis n = 686
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020. 2022 Systematic review
Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review. Human subjects in studies of psychedelic-assisted psychotherapy 2024 Systematic review and meta-analysis n = 30

Explore topics

By condition and practice